Brazil publishes Q&A for supplements regulation
This article was originally published in OTC Bulletin & The Rose Sheet
Following its complete overhaul of Brazil’s food supplements regulations, the country’s health regulatory agency, Anvisa, has published an extensive and detailed questions and answers (Q&A) document to help manufacturers navigate their way through the new rules.
You may also be interested in...
After most of the big pharmaceutical companies reported their full-year 2019 financial results, the second month of earnings season brings the long tail of smaller biotech companies and the generic pharmaceutical companies. There is more than one uncomfortable parallel from the former in the reports of the latter.
The HMA-EMA Big Data Task Force has offered recommendations to use data for the benefit of public health.